Myoinositol (600mg) + Metformin SR (500) & OVOCYST M : Tablet Essential Information on Uses, Dosage, and Side Effects

Introduction

OVOCYST M is a scientifically formulated combination of Myoinositol (600 mg) and Metformin SR (500 mg), developed primarily to support women's reproductive health, especially in cases like Polycystic Ovary Syndrome (PCOS) and insulin resistance. Manufactured with high pharmaceutical standards, this formulation targets metabolic and hormonal imbalances to improve ovulatory function and overall well-being.

Composition

• Myoinositol – 600 mg
  A naturally occurring isomer of inositol, it plays a crucial role in insulin signaling, ovarian function, and cellular health.

• Metformin SR (Sustained Release) – 500 mg
  A biguanide class anti-hyperglycemic agent that reduces hepatic glucose production and improves insulin sensitivity.

Mechanism of Action

1. Myoinositol

Myoinositol works as a secondary messenger in insulin signal transduction. It improves insulin sensitivity, restores ovulation, and enhances oocyte quality. It also balances hormonal levels in women with PCOS.

2. Metformin SR

Metformin reduces glucose absorption in the intestine and inhibits hepatic gluconeogenesis. It improves insulin sensitivity and lowers serum insulin levels, which helps restore normal ovulatory cycles in PCOS patients.

Indications

OVOCYST M is prescribed for:

• Polycystic Ovary Syndrome (PCOS)

• Anovulation or irregular menstrual cycles

• Insulin resistance

• Hyperandrogenism

• Support during infertility treatments

• Weight management in PCOS

Benefits of OVOCYST M Tablet

✅ Improves Ovulation

Restores ovulatory cycles by enhancing insulin sensitivity and balancing ovarian hormones.

✅ Regulates Menstrual Cycles

Helps normalize irregular periods, especially in women with PCOS.

✅ Supports Fertility

Improves oocyte quality and enhances pregnancy outcomes in assisted reproductive technologies (ART).

✅ Reduces Insulin Resistance

Combats hyperinsulinemia, a common feature in PCOS and metabolic syndrome.

✅ Weight Management

Metformin contributes to moderate weight loss by reducing insulin-driven fat storage.

Dosage and Administration

• Usual Dose: One tablet once or twice daily, preferably with meals or as directed by a physician.

• Form: Sustained-release for prolonged effect and improved gastrointestinal tolerance.

Important: Always follow your doctor’s prescription and advice before starting or modifying dosage.

Side Effects

OVOCYST M is generally well-tolerated. Some common side effects may include:

• Nausea

• Mild gastrointestinal discomfort

• Flatulence

• Headache

• Metallic taste (due to metformin)

Severe side effects are rare but should be immediately reported to a physician.

Precautions

• Not recommended in renal or hepatic impairment

• Use cautiously in pregnant or lactating women

• Avoid in patients with lactic acidosis

• Regular monitoring of blood sugar levels is advisable

Why Choose OVOCYST M?

Steris Healthcare's OVOCYST M stands out due to:

• Scientifically-backed formulation

• High-quality manufacturing standards

• WHO-GMP certified facility

• Better tolerability with sustained-release Metformin

Frequently Asked Questions (FAQs)

Q1. Is OVOCYST M safe for long-term use?

Yes, under medical supervision, it can be safely used for several months to manage PCOS and insulin resistance.

Q2. Can OVOCYST M help with fertility?

Yes, the combination of Myoinositol and Metformin enhances ovulatory function and egg quality, increasing chances of conception.

Q3. Does OVOCYST M cause weight loss?

While not a weight-loss medication, Metformin in the tablet may contribute to modest weight loss due to improved insulin function.

Q4. How long does it take to show results?

Results may be visible within 4 to 12 weeks, especially in terms of improved menstrual regularity and insulin sensitivity.

Conclusion

OVOCYST M is a trusted and effective solution for women dealing with PCOS, irregular cycles, insulin resistance, or fertility issues. With a potent combination of Myoinositol 600 mg and Metformin SR 500 mg, it addresses the root causes of hormonal imbalance and supports metabolic health.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW